Skip to content

Clinical trials

Phase 4 Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 4 Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20043
20062
20072
20103
20111
20121
20131
20142
20152
20161
20171
20182
20195
20201
20211
20226
20232
20243
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting9
Unknown status8
Not yet recruiting5
Active, not recruiting3
Withdrawn3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital4
Novartis Pharmaceuticals3
The First Affiliated Hospital of Soochow University3
Johnson & Johnson Private Limited2
Novartis2
PETHEMA Foundation2
Takeda2
Amgen1
Amsterdam UMC, location VUmc1
Anne Louise Tølbøll Sørensen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma52
Neoplasms3
Recurrence3
Back Pain2
Bone Neoplasms2
Breast Neoplasms2
Lymphoma2
Lymphoma, Non-Hodgkin2
Prostatic Neoplasms2
Waldenstrom Macroglobulinemia2

Trials

Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.